24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biotech
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:00
Factify builds an audit trail for enterprise AI agents making high-stakes decisions
10:00
Maolac turns cow colostrum into patented health ingredients
09:00
Kokomodo grows real cacao in a lab, no trees required
08:48
The software engineer’s role is moving beyond code
More stories
Buzz
Most popular
Daily
Weekly
1
Serbia opens Israeli drone factory as defense ties with Elbit deepen
2
The man who helped build Palo Alto’s Cortex is leaving the company
3
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
4
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
5
Sayeret Matkal veterans raise $22 million to teach the world English with AI
More news
Biotech
20 stories about Biotech
Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering
05.02.19
|
Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason
10.01.19
|
Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
Celgene Backs Immunotherapy Company Biond Biologics
08.01.19
|
Meir Orbach
Biond develops immunotherapies for cancer and autoimmune diseases
Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals
24.12.18
|
Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies
Lonza Opens Israeli Innovation Center
20.11.18
|
Lilach Baumer
The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Biotech Company Polypid Raises $15 Million
07.11.18
|
Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israel to Help Biotech Companies Go from Research to Manufacturing
04.11.18
|
Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture
28.10.18
|
Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO
28.10.18
|
Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq
22.10.18
|
Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO
21.10.18
|
Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases
Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million
18.10.18
|
Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO
30.09.18
|
Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering
20.09.18
|
Omer Kabir
The company will use the funding to launch a new model of its blood testing device, and to expand the range of tests it offers
Antiseptic Materials Startup Nobio Raises $3.6 Million
30.07.18
|
Asaf Shalev
The Israel-based startup plans to target the dental and medical device industry, offering technology to solve the infection and contamination when devices are placed in the body.
Cancer Screening Company Nucleix Raises 2.5 Million Euros
30.07.18
|
Lilach Baumer
Founded in 2008, Nucleix develops urine and blood-based non-invasive, molecular cancer screening tests
Eli Lilly Signs Multi-Year Collaboration with Anima Biotech
23.07.18
|
Lilach Baumer
Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones
Evogene Signs Brazilian Partnership to Develop Pest-Resistant Cotton
18.07.18
|
Lilach Baumer
Israel-based Evogene will identify pest-resistant genes in cotton, and Brazilian crop research Instituto Mato-Grossense do Algodão will test their effectiveness
Previous Articles
More Articles
